Genelux Corp

NAS:GNLX (USA)  
$ 2.29 +0.01 (+0.44%) 10:42 AM EST
At Loss
P/B:
4.09
Market Cap:
$ 78.67M
Enterprise V:
$ 60.72M
Volume:
52.47K
Avg Vol (2M):
273.74K
Trade In:
Volume:
52.47K
At Loss
Avg Vol (2M):
273.74K

Business Description

Description
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
Name Current Vs Industry Vs History
Cash-To-Debt 8.28
Equity-to-Asset 0.61
Debt-to-Equity 0.16
Debt-to-EBITDA -0.1
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.71
Distress
Grey
Safe
Beneish M-Score -377.64
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -29.6
3-Year EPS without NRI Growth Rate -25.6
3-Year FCF Growth Rate -41.8

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 24.83
9-Day RSI 31.3
14-Day RSI 34.45
6-1 Month Momentum % -67.69
12-1 Month Momentum % -88.31

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.72
Quick Ratio 2.72
Cash Ratio 2.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.2
Shareholder Yield % -8.71

Financials (Next Earnings Date:2024-08-14 Est.)

GNLX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GNLX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Genelux Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.008
EPS (TTM) ($) -0.97
Beta 0
Volatility % 82.65
14-Day RSI 34.45
14-Day ATR ($) 0.333911
20-Day SMA ($) 2.7415
12-1 Month Momentum % -88.31
52-Week Range ($) 2.15 - 40.98
Shares Outstanding (Mil) 34.35

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Genelux Corp Filings

Filing Date Document Date Form
No Filing Data

Genelux Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Genelux Corp Frequently Asked Questions

What is Genelux Corp(GNLX)'s stock price today?
The current price of GNLX is $2.29. The 52 week high of GNLX is $40.98 and 52 week low is $2.15.
When is next earnings date of Genelux Corp(GNLX)?
The next earnings date of Genelux Corp(GNLX) is 2024-08-14 Est..
Does Genelux Corp(GNLX) pay dividends? If so, how much?
Genelux Corp(GNLX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1